End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.46 CNY | +1.43% | +6.71% | +23.90% |
Mar. 21 | China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings | MT |
Mar. 21 | Sinopharm's 2023 Profit Climbs 9%; Shares Up 6% | MT |
Business Summary
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial
97.2
%
| 44,132 | 97.0 % | 48,294 | 97.2 % | +9.43% |
Other
2.8
%
| 1,366 | 3.0 % | 1,402 | 2.8 % | +2.59% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 45,499 | 100.0 % | 49,696 | 100.0 % | +9.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guo Tao Tian
CEO | Chief Executive Officer | 54 | 21-07-31 |
Fei Chen
DFI | Director of Finance/CFO | 49 | 23-10-13 |
Xiu Chang Jiang
CHM | Chairman | 60 | 99-11-30 |
Li Chun Luo
CMP | Compliance Officer | 43 | 00-06-30 |
Chun Yu Yang
BRD | Director/Board Member | 46 | 19-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Juan Li
BRD | Director/Board Member | 48 | 22-04-06 |
Xiu Chang Jiang
CHM | Chairman | 60 | 99-11-30 |
Xing Xi Yu
BRD | Director/Board Member | 66 | 22-04-06 |
Yong Liu
BRD | Director/Board Member | 55 | 10-03-31 |
Lu Wen Shi
BRD | Director/Board Member | 61 | 22-04-06 |
Jing Yun Liu
CHM | Chairman | 48 | 11-11-30 |
De Yong Wen
BRD | Director/Board Member | 52 | 19-05-08 |
Shen Liu
BRD | Director/Board Member | 49 | 22-04-06 |
Guo Tao Tian
CEO | Chief Executive Officer | 54 | 21-07-31 |
Chun Yu Yang
BRD | Director/Board Member | 46 | 19-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 754,502,998 | 324,089,025 ( 42.95 %) | 0 | 42.95 % |
Company contact information
China National Medicines Co., Ltd.
6-7-9/F, West Tower Xibinhe Road, Yongdingmen
100077, Beijing
+
http://www.cncm.com.cnSector
Sales per Business
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.90% | 3.7B | |
+13.02% | 69.11B | |
+5.98% | 25.91B | |
+5.02% | 8.01B | |
-3.28% | 7.91B | |
-27.52% | 7.27B | |
-0.55% | 4.51B | |
+21.54% | 4.48B | |
-2.45% | 3.95B | |
-4.12% | 3.79B |
- Stock Market
- Equities
- 600511 Stock
- Company China National Medicines Corporation Ltd.